Matthew C. Exline
Advanced in Cerebral Hypoxia

Dr. Matthew C. Exline

Pulmonary Medicine | Intensive Care Medicine
Osu Internal Medicine LLC
2050 Kenny Rd, 
Columbus, OH 
Accepting New Patients
Offers Telehealth
Advanced in Cerebral Hypoxia
Osu Internal Medicine LLC
2050 Kenny Rd, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Matthew Exline is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Columbus, Ohio. Dr. Exline is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Pneumonia, Cerebral Hypoxia, and Endoscopy. Dr. Exline is currently accepting new patients.

His clinical research consists of co-authoring 102 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Cerebral Hypoxia.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Critical Care Medicine in OH
Hospital Affiliations
Ohio State University State Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

OSU INTERNAL MEDICINE LLC
2050 Kenny Rd, Columbus, OH 43221
Other Locations
OSU INTERNAL MEDICINE LLC
410 W 10th Ave, Doan 110, Columbus, OH 43210
OSU INTERNAL MEDICINE LLC
543 Taylor Ave, Columbus, OH 43203
OSU INTERNAL MEDICINE LLC
181 Taylor Ave, Columbus, OH 43203
OSU INTERNAL MEDICINE LLC
6100 N Hamilton Rd, Westerville, OH 43081
OSU INTERNAL MEDICINE LLC
3900 Stoneridge Ln, Dublin, OH 43017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 1/2a Study of Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells (cePolyTregs) for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With SARS-CoV-2 Infection (regARDS)
A Phase 1/2a Study of Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells (cePolyTregs) for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With SARS-CoV-2 Infection (regARDS)
Enrollment Status: Terminated
Publish Date: June 05, 2023
Intervention Type: Biological
Study Drug: Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+T Regulatory Cells
Study Phase: Phase 1
Passive Immunity Trial for Our Nation (PassItOn)
Passive Immunity Trial for Our Nation (PassItOn)
Enrollment Status: Completed
Publish Date: November 03, 2022
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Phase 3
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis.
A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis.
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Drug
Study Phase: Phase 3
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Enrollment Status: Completed
Publish Date: November 18, 2019
Intervention Type: Drug
Study Phase: Phase 3
Procalcitonin Antibiotic Consensus Trial (ProACT)
Procalcitonin Antibiotic Consensus Trial (ProACT)
Enrollment Status: Completed
Publish Date: January 15, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

102 Total Publications

Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Similar Doctors
Distinguished in Cerebral Hypoxia
Dr. Ulysses J. Magalang
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Distinguished in Cerebral Hypoxia
Dr. Ulysses J. Magalang
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (7.4 miles away)
614-366-5001
Languages Spoken:
English, Filipino
See accepted insurances
Accepting New Patients
Offers Telehealth

Ulysses Magalang is a Sleep Medicine specialist and a Pulmonary Medicine provider in Dublin, Ohio. Dr. Magalang is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Drowsiness, and Cerebral Hypoxia. Dr. Magalang is currently accepting new patients.

Distinguished in Cerebral Hypoxia
Dr. Bradley R. Harrold
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Cerebral Hypoxia
Dr. Bradley R. Harrold
Pulmonary Medicine | Intensive Care Medicine

Ohiohealth Corporation

111 S Grant Ave, 2nd Fl, 
Columbus, OH 
 (3.6 miles away)
614-566-9143
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bradley Harrold is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Columbus, Ohio. Dr. Harrold is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Bronchiectasis, and Cerebral Hypoxia. Dr. Harrold is currently accepting new patients.

Distinguished in Cerebral Hypoxia
Dr. Hiten G. Shah
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Cerebral Hypoxia
Dr. Hiten G. Shah
Pulmonary Medicine | Intensive Care Medicine

Marion Area Physicians LLC

1050 Delaware Ave, 
Marion, OH 
 (39.6 miles away)
740-383-7936
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Hiten Shah is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Marion, Ohio. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, and Lung Nodules. Dr. Shah is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Exline's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile